{"id":1233,"date":"2020-02-11T10:31:16","date_gmt":"2020-02-11T09:31:16","guid":{"rendered":"http:\/\/invivo.partners\/portoflio_invivo\/pulmobiotics\/"},"modified":"2021-09-02T16:14:32","modified_gmt":"2021-09-02T14:14:32","slug":"pulmobiotics","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/","title":{"rendered":"Pulmobiotics"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Pulmobiotics es una empresa <em>spin-off<\/em> del <strong>Centro de Regulaci\u00f3n Gen\u00f3mica<\/strong> (CRG). Es una empresa de ciencias de la vida en fase precl\u00ednica que utiliza la biolog\u00eda sint\u00e9tica para desarrollar una novedosa <strong>plataforma bioterap\u00e9utica <\/strong>para tratar enfermedades pulmonares humanas. La <strong>plataforma<\/strong> se basa en bacterias pulmonares atenuadas capaces de administrar agentes terap\u00e9uticos en el pulm\u00f3n con diferentes actividades, por ejemplo, antimicrobianas, de regeneraci\u00f3n de tejidos y de modulaci\u00f3n del sistema inmunitario.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>CEO: Claudio Santos<\/li><li>CSO y cofundadora: Dra. Maria Lluch<\/li><li>Asesor y Cofundador: Prof. Luis Serrano<\/li><li>Ubicaci\u00f3n: Barcelona<\/li><li>P\u00e1gina web: <strong><a rel=\"noreferrer noopener\" href=\"https:\/\/www.pulmobio.com\/\" target=\"_blank\">pulmobio.com<\/a><\/strong><\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[507],"class_list":["post-1233","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventures"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pulmobiotics - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulmobiotics - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Pulmobiotics es una empresa spin-off del Centro de Regulaci\u00f3n Gen\u00f3mica (CRG). Es una empresa de ciencias de la vida en fase precl\u00ednica que utiliza la biolog\u00eda sint\u00e9tica para desarrollar una novedosa plataforma bioterap\u00e9utica para tratar enfermedades pulmonares humanas. La plataforma se basa en bacterias pulmonares atenuadas capaces de administrar agentes terap\u00e9uticos en el pulm\u00f3n con\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-02T14:14:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/\",\"url\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/\",\"name\":\"Pulmobiotics - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-02-11T09:31:16+00:00\",\"dateModified\":\"2021-09-02T14:14:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulmobiotics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulmobiotics - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/","og_locale":"es_ES","og_type":"article","og_title":"Pulmobiotics - Invivo Partners","og_description":"Pulmobiotics es una empresa spin-off del Centro de Regulaci\u00f3n Gen\u00f3mica (CRG). Es una empresa de ciencias de la vida en fase precl\u00ednica que utiliza la biolog\u00eda sint\u00e9tica para desarrollar una novedosa plataforma bioterap\u00e9utica para tratar enfermedades pulmonares humanas. La plataforma se basa en bacterias pulmonares atenuadas capaces de administrar agentes terap\u00e9uticos en el pulm\u00f3n con","og_url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/","og_site_name":"Invivo Partners","article_modified_time":"2021-09-02T14:14:32+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/","url":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/","name":"Pulmobiotics - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-02-11T09:31:16+00:00","dateModified":"2021-09-02T14:14:32+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/portoflio_invivo\/pulmobiotics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"Pulmobiotics"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo\/1233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=1233"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tipo_portfolio?post=1233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}